Opdivo FAQs

Question 1

How much does Opdivo cost without insurance?

Accepted Answer

Opdivo costs around $5,379.25 for 1, 12ml of 120mg/12ml vial for uninsured customers. With a SingleCare Opdivo coupon, people can pay as low as $4,043.08 for 1, 12ml of 120mg/12ml vial of Opdivo if the hospital or clinic where you receive Opdivo infusions will accept SingleCare. SingleCare is a free service available in the United States and Puerto Rico, offering savings at your participating local pharmacy. Check the SingleCare site for more information.

Question 2

How much does Opdivo cost with insurance?

Accepted Answer

Your copay for Opdivo with insurance will vary depending on your insurance company and the price charged for Opdivo by the hospital or clinic where you get your infusion. However, Opdivo may be covered by your health insurance as a medical benefit rather than a prescription drug benefit. Ask the clinic or hospital where you receive Opdivo infusions if they will accept a SingleCare Opdivo coupon; you could pay $4,043.08 for 1, 12ml of 120mg/12ml vial. You can also sign up for the BMS Access Support Program, a patient support program offered by the manufacturer. This program provides resources on understanding insurance coverage as well as information about co-payment assistance for eligible patients, patient assistance programs, and other types of financial assistance and support.

Question 3

Does Medicare cover Opdivo and how much does it cost?

Accepted Answer

Opdivo is usually not covered under Medicare prescription drug plans, such as Medicare Part D and Medicare Advantage Plans. However, it should be covered under Medicare Part A or B as a medical benefit, depending on where you receive your infusion. Ask the clinic or hospital where you receive Opdivo infusions if they will accept a SingleCare Opdivo coupon; you could pay $4,043.08 for 1, 12ml of 120mg/12ml vial.

Question 4

Is there a generic of Opdivo?

Accepted Answer

Opdivo is a brand-name prescription drug with the active ingredient, nivolumab. Generic nivolumab is not available at this time.

Question 5

What is Opdivo?

Accepted Answer

Opdivo is a brand-name prescription injection that treats a number of cancers. This medication is used alone or with a medication called Yervoy (ipilimumab) and/or other chemotherapy drugs: The active ingredient in Opdivo, nivolumab, restores the immune system's ability to fight off cancer cells. It helps the immune system slow or stop cancer cell growth. Opdivo is administered by a healthcare provider as an intravenous infusion in a healthcare setting. The infusion usually lasts at least 30 minutes. If given alone, Opdivo is generally administered every 2 or 4 weeks. When Opdivo is given in combination with Yervoy or other chemotherapy, it is generally given every 2, 3, or 4 weeks. Your healthcare provider will advise you on a schedule. There are many warnings and precautions associated with this medication. Before taking Opdivo, let your doctor know about any medical conditions you have and all the medications you take, including prescription and OTC drugs, vitamins, and supplements. Be sure to let your doctor know if you are pregnant, planning to become pregnant, or breastfeeding.

Question 6

What are the side effects of Opdivo?

Accepted Answer

Side effects can vary, based on whether you are receiving Opdivo alone or with other medication. When taken alone, common side effects of Opdivo include, but are not limited to: When taking Opdivo in combination with Yervoy or other chemotherapy medications, side effects will depend on which drugs are in your treatment regimen. You can ask your healthcare provider any questions you have, as well as request more information and a full list of side effects. Serious allergic reactions may occur, and require emergency medical attention. Symptoms may include hives, difficulty breathing, or swelling of the face, lips, tongue, or throat. Severe, life-threatening skin reactions also require emergency medical help. Symptoms may include fever, burning eyes, sore throat, skin pain, red or purple rash, or blistering or peeling skin. Other serious side effects may include:

Question 7

What is the difference between Opdivo and Keytruda?

Accepted Answer

Opdivo contains the active ingredient nivolumab and is made by the pharmaceutical company Bristol-Myers Squibb. Keytruda contains the active ingredient pembrolizumab and is made by Merck & Co. Both drugs are classified as programmed death receptor-1 (PD-1)-blocking antibodies, and they work the same way. Both drugs are FDA-approved to treat many types of the same cancers, such as bladder cancer, kidney cancer, melanoma, and lung cancer—although they have some differences in the types of cancers they treat. Keytruda has some more FDA-approved uses than Opdivo. The dosage and frequency also vary, among other differences. You can talk to your doctor for more information about these medications.

Opdivo

About Opdivo

Popular Prescriptions

Browse drugs A-Z:

Subscribe to our savings newsletter

Opdivo

About Opdivo

Related Drugs

Related Drug Classes

Related Conditions

Popular Prescriptions

Browse drugs A-Z:

Subscribe to our savings newsletter